<DOC>
	<DOCNO>NCT01735318</DOCNO>
	<brief_summary>This randomize , balance , open Label , two-treatment , two-period , two-sequence , single dose , crossover pivotal study . The purpose study assess bioequivalence Test Product correspond Reference Product fast condition normal , healthy , adult , male female human subject .</brief_summary>
	<brief_title>Bioequivalence Study Lisinopril Tablets 40 mg Under Fasting Condition</brief_title>
	<detailed_description>Objective pivotal study assess bioequivalence Test Product : Lisinopril Tablets 40 mg Ipca Laboratories Limited , India correspond Reference Product : Zestril® ( Lisinopril ) 40 mg Tablets AstraZeneca Pharmaceuticals LP USA , fast condition normal , healthy , adult , male female human subject randomize crossover study . The study conduct 40 healthy adult subject . In study period , single 40 mg dose either test reference administer subject per randomization schedule study period 240 mL water ambient temperature sit position . The duration clinical phase approximately 19 day include washout period 15 day administration study drug study period .</detailed_description>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>1 . Male non pregnant female human subject , age range 18 45 year . 2 . Body weight within ± 15 % ideal weight relate height body frame accord Life Insurance Corporation ( LIC ) Chart . 3 . Subjects normal finding determine baseline history , physical examination vital sign examination ( blood pressure , pulse rate , respiration rate axillary temperature ) . 4 . Subjects clinically acceptable finding determine haemogram , biochemistry , urinalysis 12 lead ECG . 5 . Willingness follow protocol requirement especially abstain xanthine contain food beverage ( chocolate , tea , coffee cola drink ) grapefruit juice , alcoholic product , use cigarette tobacco product 48 hour prior dose last blood sample collection study period adherence food , fluid posture restriction . 6 . No history significant alcoholism . 7 . No history drug abuse ( benzodiazepine barbiturate ) last one month illegal drug last 6 month . 8 . Nonsmokers include . 1 . Known history hypersensitivity Lisinopril relate drug . 2 . Requiring medication ailment enzymemodifying activity previous 28 day , prior dose day . 3 . Subjects take prescription medication overthecounter product ( include vitamin mineral ) within 14 day prior administration Investigational Product . 4 . Any medical surgical condition , might significantly interfere function gastrointestinal tract , bloodforming organ etc . 5 . History cardiovascular , renal , hepatic , ophthalmic , pulmonary , neurological , metabolic , haematological , gastrointestinal , endocrine , immunological psychiatric disease . 6 . Participation clinical drug study bioequivalence study 90 day prior present study . 7 . History malignancy serious disease . 8 . Blood donation 90 day prior commencement study . 9 . Subjects positive HIV test , HBsAg HepatitisC test . 10 . Found positive breath alcohol test . 11 . Found positive urine test drug abuse . 12 . History problem swallowing . 13 . Any contraindication blood sampling . 14 . Found positive serum Beta hCG ( Human Chorionic Gonadotropin ) test . 15 . Lactating woman ( currently breast feed ) . 16 . Female subject confirm use birth control measure , date screening completion study . Abstinence , barrier method ( condom , diaphragm , etc . ) acceptable . Use hormonal contraceptive either oral implant . 17 . Female subject whose menstruation cycle coincide study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>